以岭药业:全资子公司获得药品注册证书

Core Viewpoint - Yiling Pharmaceutical has received approval from the National Medical Products Administration for the marketing authorization of its product, Valaciclovir Hydrochloride Tablets, through its wholly-owned subsidiary, Yiling Wanzhou International Pharmaceutical [1] Group 1 - Yiling Pharmaceutical's wholly-owned subsidiary, Yiling Wanzhou International Pharmaceutical, submitted a marketing authorization application for Valaciclovir Hydrochloride Tablets [1] - The approval from the National Medical Products Administration includes the issuance of a drug registration certificate [1]

YILING PHARMACEUTICAL-以岭药业:全资子公司获得药品注册证书 - Reportify